The findings from qRT-PCR and immunohistochemistry (IHC) analyses revealed a significant upregulation of both FOXP3 mRNA and protein levels in GBM tissues compared to non-tumor brain tissues (Fig. 1E, F). The gene discussed is FOXP3; the disease is neoplasm.